High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$105K
$105,409
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CTNM
M
Contineum Therapeutics, Inc.
Watkins Tim
• Officer • CMO & Head of Development
Other
2026-03-02
$16,250
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • CMO & Head of Development
Other
|
2026-03-02 | $16,250 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Watkins Tim
• Officer • CMO & Head of Development
10b5-1 Sell
2026-03-02
$54,220
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • CMO & Head of Development
10b5-1 Sell
|
2026-03-02 | $54,220 | S | Form 4 |
|
CTNM
M
Contineum Therapeutics, Inc.
Watkins Tim
• Officer • CMO & Head of Development
Other
2026-01-28
$16,250
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • CMO & Head of Development
Other
|
2026-01-28 | $16,250 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Watkins Tim
• Officer • CMO & Head of Development
10b5-1 SellΔOwn -77.5%
2026-01-28
$39,441
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • CMO & Head of Development
10b5-1 SellΔOwn -77.5%
|
2026-01-28 | $39,441 | S | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Watkins Tim
• Officer • CMO & Head of Development
10b5-1 Sell
2026-01-28
$11,747
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • CMO & Head of Development
10b5-1 Sell
|
2026-01-28 | $11,747 | S | Form 4 |